A metal‐organic framework (MOF) Fenton nanoagent‐enabled nanocatalytic cancer therapy in synergy with autophagy inhibition

B Yang, L Ding, H Yao, Y Chen, J Shi - Advanced materials, 2020 - Wiley Online Library
Nanocatalytic medicine has been developed recently to trigger intratumoral generation of
highly toxic reactive oxygen species (ROS) for cancer therapy, which, unfortunately, suffers …
被引用次数：268 相关文章

A Metal‑Organic Framework (MOF) Fenton Nanoagent‑Enabled Nanocatalytic Cancer Therapy in Synergy with Autophagy Inhibition

B Yang, L Ding, H Yao, Y Chen, J Shi - Advanced Materials, 2020 - ui.adsabs.harvard.edu
Nanocatalytic medicine has been developed recently to trigger intratumoral generation of
highly toxic reactive oxygen species (ROS) for cancer therapy, which, unfortunately, suffers …

A Metal-Organic Framework (MOF) Fenton Nanoagent-Enabled Nanocatalytic Cancer Therapy in Synergy with Autophagy Inhibition

B Yang, L Ding, H Yao, Y Chen… - … (Deerfield Beach, Fla.), 2020 - pubmed.ncbi.nlm.nih.gov
Nanocatalytic medicine has been developed recently to trigger intratumoral generation of
highly toxic reactive oxygen species (ROS) for cancer therapy, which, unfortunately, suffers …

A Metal-Organic Framework (MOF) Fenton Nanoagent-Enabled Nanocatalytic Cancer Therapy in Synergy with Autophagy Inhibition.

B Yang, L Ding, H Yao, Y Chen, J Shi - … Materials (Deerfield Beach …, 2020 - europepmc.org
Nanocatalytic medicine has been developed recently to trigger intratumoral generation of
highly toxic reactive oxygen species (ROS) for cancer therapy, which, unfortunately, suffers …